首页 | 本学科首页   官方微博 | 高级检索  
     

舒肝解郁胶囊治疗进展期胃癌并发抑郁症的临床研究
引用本文:吴永胜,;万平新,;万顺梅,;葛勤利,;杨伟捷,;刘福侠. 舒肝解郁胶囊治疗进展期胃癌并发抑郁症的临床研究[J]. 现代消化及介入诊疗, 2014, 0(3): 150-152
作者姓名:吴永胜,  万平新,  万顺梅,  葛勤利,  杨伟捷,  刘福侠
作者单位:[1]解放军第一医院,730030; [2]甘肃省白银市靖远县中医院,730060
摘    要:目的探讨舒肝解郁胶囊治疗进展期胃癌并发抑郁症的临床疗效。方法明确诊断的82例胃癌晚期患者在化疗基础上分为治疗组41例(给予舒肝解郁胶囊治疗)和对照组41例(给予姑息治疗),两组患者使用汉密顿抑郁量表(HAMD)评定患者的抑郁状态及其舒肝解郁胶囊治疗抑郁的疗效。结果经6周治疗后,两组患者临床症状均获改善,且总有效率比较有显著性差异(P0.05),治疗组抑郁症疗效明显优于对照组(χ2=7.68,P0.01),两组治疗前后HAMD评分比较有显著性差异(P0.01)。结论舒肝解郁胶囊治疗进展期胃癌并发抑郁症,临床疗效较好。

关 键 词:舒肝解郁胶囊  抑郁症  胃恶性肿瘤

Clinical observation of shuganjieyu capsule in treating depressed patients from advanced gastric cancer
Affiliation:WU Yong-sheng, WAN Ping-xin, WAN Shun-mei, GE Qin-li, YANG Wei-jie, LIU Fu-xia ( 1. First Hospital of People's Liberation Army in Lanzou 730030; 2) Jingyuan Hospital of Traditional Chinese Medicine, Baiyin 730600, China)
Abstract:Objective To investigate the clinical effects of shuganjieyu capsule in treating depressed patients with advanced gastric cancer. Methods Eighty two depressed patients resulting from gastric cancer were randomly divided into treatment group and control group, 41 patients in each group. The depressive status and efficacy of shuganiieyu capsule were evaluated by Hamilton (HAMD). Results Clinical symptoms were improved in both groups, but there was significant difference between groups based on self-reported symptoms (X2=7.68, P〈0.01). Depression scores were significantly lower after treatment than before treatment (P〈0.01). Conclusion Shuganjieyu capsule have better clinical efficacy in treating depressed patients due to ad-vanced gastric cancer.
Keywords:Shuganjieyu capsule  Depression  Gastric Cancer
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号